Protective Efficacy and Immunogenicity of Rv0351/Rv3628 Subunit Vaccine Formulated in Different Adjuvants Against Mycobacterium tuberculosis Infection
Open Access
- 1 January 2023
- journal article
- research article
- Published by XMLink in Immune Network
- Vol. 23 (2)
Abstract
Kwon KW, et al. Immune Netw. 2023 Feb;23(2):e16. https://doi.org/10.4110/in.2023.23.e16Keywords
Funding Information
- Korea Health Industry Development Institute (HV20C0144, HV20C0139, HV22C0079)
- Yonsei University (2021-12-0156)
This publication has 56 references indexed in Scilit:
- Local and systemic immune responses in pigs intramuscularly injected with an inactivated Mycoplasma hyopneumoniae vaccineVaccine, 2013
- The Mincle-Activating Adjuvant TDB Induces MyD88-Dependent Th1 and Th17 Responses through IL-1R SignalingPLOS ONE, 2013
- The HyVac4 Subunit Vaccine Efficiently Boosts BCG-Primed Anti-Mycobacterial Protective ImmunityPLOS ONE, 2012
- Efficacy Results of a Trial of a Herpes Simplex VaccineNew England Journal of Medicine, 2012
- High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol CatabolismPLOS Pathogens, 2011
- Retinoic Acid as a Vaccine Adjuvant Enhances CD8+T Cell Response and Mucosal Protection from Viral ChallengeJournal of Virology, 2011
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosisScience Translational Medicine, 2010
- Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeysProceedings of the National Academy of Sciences, 2009
- Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosisProceedings of the National Academy of Sciences, 2007
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007